Potential Blood Clot Risk of COVID Vaccine Shines a Spotlight on Inequality Around Women’s Health

The news that under-30s will be offered an alternative to the Oxford/AstraZeneca jab has sparked a debate about women’s reproductive and contraceptive healthcare, reports Sian Norris